Subject: Proxy/Proxy Vote

Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Boston Millennia Partners ("Boston Millennia"), a significant shareholder of SomaLogic (the "Company") (Nasdaq: SLGC) today announced that it intends to vote against the Company's planned merger (the "Merger") with Standard BioTools Inc. (Nasdaq: LAB).

News published on 31 december 2023 at 14:15 and distributed by: